Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed.
↵i The notion of ‘fairness’ that is at work in the context of ‘fair rationing’ is usually understood more narrowly than it is in other contexts. Questions of fairness, more broadly conceived, will also arise in connection with the size of the budget allocated to healthcare: for example, concerns of fairness are likely to be relevant when deciding how much to allocate to healthcare relative to, for instance, education. I leave these issues aside for the purposes of the present discussion.
↵ii There may be instances where clinicians can redress the resource shortages their previous, inefficient decisions have created, for example by working unpaid overtime or providing private funds. In such cases, clinicians arguably have a duty to provide such redress (although of course whether or not we would want to enforce such a duty as a matter of policy is a separate question). I thank an anonymous reviewer for raising this point.
Read the full text or download the PDF:
Other content recommended for you
- How can bedside rationing be justified despite coexisting inefficiency? The need for ‘benchmarks of efficiency’
- “No decisions about us without us”? Individual healthcare rationing in a fiscal ice age
- Antimicrobial stewardship programmes: bedside rationing by another name?
- Three pitfalls of accountable healthcare rationing
- Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population?
- Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
- Non-maleficence and the ethics of consent to cancer screening
- Evaluating a patient's request for life-prolonging treatment: an ethical framework
- Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
- An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation